Rate of obesity has increased all over the world. Indications and contraindications for obesity surgery have not changed much; however, metabolic consequences of bariatric surgery have expanded some indications for obesity surgery in patients with comorbidities. The advancement and frequent usage of laparoscopic surgery have made bariatric surgical operations easier.
Introduction
As Buchwald says "to know what is new, one must know what is old". [1] From this point of view, reviewing obesity history is a crucial step to understanding current definitions and indications. Bariatric surgery is a dynamic surgical field and changes have continued in recent years. [1, 2] The word "bariatric" comes from the Greek words "baros", meaning weight and "iatrikos", meaning the art of healing. This word has been used to define gastrointestinal operations for obese patients in order to help them lose weight. [3] Humans have evolved from an active nomadic hunter-gatherer (consuming a high protein diet) to a settled farming species over the millennium. This sedentary life change is an important factor forobesity. [4] While obesity was an icon representing power, heath, and wealth in ancient times, it is now accepted as a disease to be treated. [5] In the 1950s, conservative treatment of morbid obesity was often unsuccessful. The first operation was performed to treat severe hyperlipidemia associated with obesity. History of bariatric surgery started with jejunoileal bypass by Varco. [1, 4, 6] This operation limited absorption; however, it had some severe nutritional complications and liver failure postoperatively.
In 1966, Mason and Ito performed the first gastric bypass but the bile reflux e ophagitis was severe postoperatively. Roux-en-Y modification of the gastric bypass was developed by Griffinin 1977. [1, 4] Scopinaro developed and popularized the biliopancreatic diversion (BPD) procedure in the late 1970s. This procedure is mainly malabsorptive and still used by few su geons throughout the world (<5%). [1, 4] In 1980, Mason described vertical banded gastroplasty (VBG) as a restrictive procedure causing excellent initial weight loss with low morbidity and mortality. It rapidly b came the most commonly performed bariatric operation in the United States during the 1980s. [1, 4, 7] Afterwards [1, [8] [9] [10] [11] [12] [13] [14] [15] There have been two major changes in the bariatric field recently. Firstly, laparoscopic development has increased the number of laparoscopic bariatric operations and made them easier than they were before. Secondly, nowadays, the concept of bariatric surgery is covering the ability of surgical therapy to treat the metabolic consequences of obesity more than obesity itself. [2, 8, [16] [17] [18] Bariatric and metabolic surgery are proven therapies for obesity and its comorbidities. With bariatric surgery, not only the resolution or improvements of co-morbidities such as diabetes, hypertension, hyperlipidemia, obstructive sleep apnea, gastroesophageal reflux, and pseudo tumor cerebri occur, but also the prevalence of development of some type of cancers like breast and colon cancers decrease. Furthermore, bariatric surgery improves overall quality of life and causes long-term survival. [19, 20] 
Definition
Accepting and understanding obesity as a problem is the first step to dealing with it. Obesity has morbidity and mortality risks and it is a severe chronic disease consisting complex genetics and environmental causes. The term morbid applies to obesity in order to explain serious, progressive, and debilitating disease. [4, 6] According to the World Health Organization (WHO), obesity and overweight are defined abnormal or excessive fat accumulation that may impair health. [21] The imbalance between excess calorie intake and relatively less energy expenditure causes obesity. [21, 22] Obesity is a growing medical and socioeconomic problem, which WHO defined as the epidemic disease of the new age world called globosity. [17, 23] 
Prevalence
Obesity is a worldwide epidemic that currently affects both developed and developing countries. Obesity is the second leading cause of preventable death in the world. [17, 24] According to WHO, 1.7 billion adults, 20 years and older, were overweight or obese in 2008. 200 million men and nearly 300 million women were obese. Studies have shown that in the United States, United Kingdom and Australia, the prevalence of obesity in adults has doubled in the last 25 years. Obesity prevalence in Europe ranges between 40 and 60%. [1, 12, 17, 20, 21, [25] [26] [27] [28] [29] Obesity prevalence has increased over the last 20 years in the United States of America and currently ranks second in the world. Nearly two thirds of Americans are overweight or obese and almost 5% are morbidly obese. In 2008, there were more than nine million morbidly obese Americans needing help. [1, 30] As similar in 2011 and 2012, 63% of Australian adults had a body mass index (BMI) in either the overweight or the obese category. Being overweight was more prevalent among males than females (42% vs. 35%) and obesity prevalence was similar among males and females (28%). [6, 31] Obesity prevalence in Turkey is almost the same as the prevalence in developed western countries. According to apreliminary study report called "Nutrition and Health Research of Turkey" conducted by the Ministry of Health, obesity prevalence in Turkey is 20.5% among males and 41% among females. The total rate of overweight and obese is 64.9% and rate of morbidly obese is 2.9% in Turkey. [32] The image of obesity among adolescents is the same as adults. Obesity prevalence has also increased among adolescents. The rate of extremely obese (defined as BMI ≥99 th percentile) is 4% among adolescents. [33] The prevalence of obesity among adolescents has reached 35.8% in Latin America, 18.3% in England, and 16, 5% in the U.S. In our country, the prevalence is 8.2%. [32, 34] Prevalence of type 2 diabetes (T2DM) has risen is parallel to the increasing prevalence of obesity. In 2011, an estimated 366 million people had diabetes and this number will have reached to 522 million by 2030. [35] Overweight and obesity are the problems of our generation. The number of bariatric surgical procedures performed worldwide has increased by 761% over the last decade. [6, 23] The dispersion of obesity in the world is shown in Figure 1 and in Figure 2 in Turkey. [17, 20, [25] [26] [27] [28] Later, some more definitions have been added to this classification system. BMI more than 50 is defined super morbid obese and greater than 60 is defined super morbid obesity. [2, 16, [36] [37] [38] Definitions of overweight and obesity are based on the cri- teria coming from studies involving the populations of European origin. [25] Nevertheless, different populations have different associations between BMI, percentage of body fat, and health risk. [20] Other methods to classify obesity include waist circumference and central and peripheral fat mass. [16] 
Classification of Obesity

Indications for Obesity Surgery
Indications for obesity surgery were firstly described by the NIH Consensus Conference of 1991 and there have been a few changes so far. The guidelines have generally focused on bodymass index (BMI) and the presence of comorbidities. [2, 19, 26, 39] Traditional indications defining the NIH consensus conference for obesity surgery included the patients whose BMI exceeds 40 kg/m 2 or 35 kg/ m 2 in the presence of comorbidities (such as metabolic disorders, cardio respiratory disease, severe joint disease, obesityrelated severe psychological problems) and when conservative treatment has failed. The term "when conservative treatment has failed" is newly replaced by the term "when conservative treatment has exhausted", meaning the treatment goal of 10 to 20% weight loss in a patient whose BMI is 35 to 40 kg/m 2 or 10 to 30% in a patient whose BMI exceeds 40 kg/m 2 cannot be reached and maintained in 6 to 12 months of treatment. [19, 23] According to Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery published in 2013 by Fried et al., indications for obesity surgery cover extra criteria. [17] In addition to classical NIH's indications, BMI ≥40 kg/m 2 and BMI 35-40 kg/m 2 with co-morbidities, the other extra indication is the current BMI of the patient being below than required for surgery due to weight loss as a result of intensified treatment before surgery.
BMI alone is not an ideal parameter for defining indications for bariatric surgery in patients who have T2DM. Due to the fact that definitions of overweight and obesity are based on the criteria of European origin, BMI threshold should be adjusted by 2.5 for individuals of Asian origin. [17, 25] The American Society for Bariatric and Metabolic Surgery (ASMBS), the American Association of Clinical Endocrinologists (AACE), and the International Diabetes Federation (IDF) have agreed on considering bariatric and metabolic surgery in patients with a BMI of 30-34.9 kg/m 2 and diabetes or metabolic syndrome. [40] [41] [42] The U.S. Food and Drug Administration (FDA) approved the Lap-Band TM for patients with a BMI of 30-34.9 kg/m 2 and obesity-related co-morbidities. [16, 19, 43] According to IFSO-APC Consensus Statements in 2011, surgical approach may be considered as a non-primary alternative to treat inadequately controlled T2DM or metabolic syndrome for suitable Asian candidates with a BMI ≥27.5 kg/m. [2, 25] Indication for obesity surgery in adolescents and children could be considered in centers with extensive experience of such treatment in adults and in ones that are able to offer a true multidisciplinary approach, involving pediatric surgeon, dietician and psychological management team. [17] There are two concepts related to the indications in adolescents. On the one hand, obesity surgery can be considered if the patient has a BMI >40 kg/m 2 (or 99.5 th percentile for respective age) and at least one co-morbidity or BMI ≥50 kg/m 2 with or without major co-morbidities. [17, 24] On the other hand, according to the guideline of Australia and New Zealand, indications for obesity surgery among adolescents are same as adult indications comprising a BMI ≥40 kg/m 2 and BMI 35-40 kg/m 2 with the presence of severe obesity related complications. [19, 44] The NIH statement noted that the surgical candidate should be evaluated by a multidisciplinary team consistingmedical, surgical, psychiatric, and nutritional specialists. The advantages and disadvantages of all treatment options should be discussed with the patient and/he should be involved in the treatment. [19, 26] 
Contraindications for Obesity Surgery
There are few absolute contraindications for metabolic and obesity surgery and most of them are same as elective general surgeries', such as uncontrolled coagulopathy and contraindication to general anesthesia. [2, 19] Bariatric surgery should not be performed on patients with limited life expectancy due to end organ failure and metastatic or inoperable malignancies. In patients willing to get pregnant within 12 months or are pregnant, the operation should be deferred. [19] European Guidelines on Metabolic and Bariatric Surgery stated that following situations are contraindications of bariatric and metabolic surgery: [17] absence of a period of identifiable medical management, patient who is unable to participate in the prolonged medical follow-up, nonstabilized psychotic disorders, severe depression, personality and eating disorders, unless specifically advised by a psychiatrist experienced in obesity, and alcohol abuse and/or drug dependencies. Furthermore, bariatric surgery may be contraindicated for patients who are unable to care for themselves and have nosocial support. For diabetes, the specific exclusion criteria for metabolic surgery are secondary diabetes and antibodies positivity (anti-GAD or anti-ICA) or C-peptide <1 ng/mL or being unresponsive to mixed meal challenge.
Relative contraindications for obesity and metabolic surgery are patients' impaired intellectual capacity, malignant hyperphagia and resistance to life changing modifications in post bariatric term. [19] Genetic syndrome like Prader-Willi was a contraindication before. However, some case reports have shown that bariatric surgery among this population can be effective. [17, 19, 45] There is a need to carry out more studies to show the effectiveness of bariatric surgery among this population.
Specific Situations
Although the prevalence of morbid obesity has been rising among elderly patients recently, the majority of operated patients are younger than 50 years of age. In the UK, the mean age of patients undergoing bariatric surgery is 40-43 years. Due to the perceived complication risks and poor outcomes of surgery, most bariatric surgeons are frightened to propose bariatric surgery to older patients. [46] Although age limit is shown by European Guidelines on Metabolic and Bariatric Surgery as between 18 to 60 years of age in adults, no higher age limit for bariatric surgery was recommended in the NIH conference in 1991. [17, 19, 26] At the time of publication, there was insufficient data to make a recommendation for or against surgery for adolescent population. [19] Busetto et al. have not found any differences between the age groups of 60-69 and 70-79 years in terms of an improvement in weight loss and co-morbidities. [47] In light of the current studies, metabolic and bariatric surgery should be performed on selected patients aged 65 and older. [17, 19, 46] Baur et al. recommenda minimum of 15 years of age for adolescents. Since the effects of bariatric surgery is unknown among preadolescents, it is not recommended for this group. [19, 44] 
Psychiatric Illness
It has been shown that around 40% of all bariatric surgery patients have at least one psychiatric diagnosis. [48] Presence of psychopathology, including eating disorders, is not a contraindication of bariatric and metabolic surgery. Some successful outcomes have been obtained among patients having major depressive disorders, bipolar disorders, stable schizophrenia, and binge eating. Preoperative psychiatric evaluation is mandatory in order to maintain therapy for stable disorders. For patients with active psychoses or recent hospitalization, suicidal idea, and recent suicidal attempt, surgery should be delayed or postponed. [19, 48] 
Cirrhosis
Obesity is associated with fatty liver disease. The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) range from 84-96% and 25-55%, respectively, among obese patients. [49] The incidence of unexpected cirrhosis is 2% during bariatric surgery. [19, 49] Patients with known cirrhosis should be carefully evaluated preoperatively. The cause of cirrhosis should be determined and hepatic function should be assessed by Child-Pugh classification. The presence of portal hypertension should be evaluated in addition to the regular preoperative workup for bariatric patients. If evidence of portal hypertension is detected during surgery, the operation should be stopped. [19, 49, 50] It has been shown that weight loss improves the histological findings of steatosis and steatohepatitis. Surgery may be safely conducted in stable cirrhotic patients. This type of challenging operations should be performed in selected tertiary centers experienced in liver transplant. [19, 49] 
HIV Infection
Because of acquired immunodeficiency due to weight loss after bariatric surgery, HIV positivity was thought as a contraindication for bariatric operations. Modern antiretroviral therapy has dramatically improved prognosis of the disease and extended life expectancy. Two years after antiretroviral therapy, lipodystrophy causes overweight and obesity up to 20% in the HIV population. Although there is debate about bariatric surgery for HIV positive group, there have been reported case series demonstrating safety and efficacy of metabolic and bariatric surgery with stable HIV infection. [19, 50] 
Non-Ambulatory Patients
Some guidelines and programs accept non-ambulatory as a contraindication of bariatric surgery. However, obesity has aggravated co-morbidities among non-ambulatory patients. The profit of bariatric surgery by inducing weight loss is considered for this group. In selected non-ambulatory patients, bariatric and metabolic surgery should be performed in atertiary center. [19] 
Conclusion
Although the number of bariatric operations has increased in years due to the usage of laparoscopic techniques, unfortunately, still only 1% of obese patients can be treated. [8, 22] The indications of metabolic and obesity surgery should be based on not only BMI but also on metabolic comorbidities With the development of laparoscopic surgery, bariatric surgery has gained popularity and the indications of bariatric surgery have extended.
